Fora Capital, LLC Denali Therapeutics Inc. Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $101,606 - $158,448	-2,020 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $108,676 - $164,690	2,020 New	2,020 $115 Million
Q4 2020 Feb 12, 2021	SELL	$36.89 - $93.56 $67,840 - $172,056	-1,839 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$23.13 - $38.84 $42,536 - $71,426	1,839 New	1,839 $66 Million

234

127M

37.3K

7.9K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.87B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.